论文部分内容阅读
目的探讨爱迪注射液对老年肿瘤患者的疗效及其对免疫功能的影响。方法将2004～2008年收治的136例老年恶性肿瘤患者随机分为治疗组和对照组,评估两组患者治疗后生活质量及免疫功能的变化。结果有效率治疗组为44.1%,对照组为32.3%,有统计学意义。生活质量评分治疗组高于对照组,组间差异有统计学意义。治疗组治疗后NK细胞活性及T细胞免疫表型显著提高。结论爱迪注射液用于治疗老年肿瘤患者可改善其免疫功能,提高生活质量,延长生存期。
Objective To investigate the therapeutic effect of Aidi Injection on elderly patients with cancer and its effect on immune function. Methods A total of 136 elderly patients with malignant tumors who were admitted from 2004 to 2008 were randomly divided into treatment group and control group. The quality of life and immune function of the two groups were evaluated. Results The effective treatment group was 44.1%, the control group was 32.3%, with statistical significance. The quality of life score in the treatment group was higher than that in the control group, with significant difference between the groups. After treatment, NK cell activity and T cell immunophenotype were significantly increased in treatment group. Conclusion Aidi injection for the treatment of elderly patients with cancer can improve their immune function, improve quality of life and prolong survival.